Efficacy and durability of GB10, a novel bispecific VEGF/Ang-2 neutralizing fusion protein, in ocular neovascularization models.

Journal: Frontiers in pharmacology •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Hao M, You Q, Wei X, et al. (2026). "Efficacy and durability of GB10, a novel bispecific VEGF/Ang-2 neutralizing fusion protein, in ocular neovascularization models.". Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1974368